Replies to post #293521 on Anavex Life Sciences Corp (AVXL)

[LBSR TO DA MOON]

Get stat significant results from the 450 participant AD trial, partners will be knocking down Missling’s door and we’ll see the $20B market cap. That’s what I’m waiting for...

I pray (for more than just monetary reasons) that your prediction above comes to fruition in due time...

[raja48185]

Get stat significant results from the 450 participant AD trial, partners will be knocking down Missling’s door and we’ll see the $20B market cap. That’s what I’m waiting for...

20 Billion MC will be less if AVXL can tame AD.


It is going to be a real challenge. Definitely not a walk in the park. Else the company would have provided updates with almost 4 year ongoing extended trial - mere observations by now would have given enough clues.

Hopefully, the lessons learned will be incorporated into trial design - from patient selection to dosage, metrics and outcomes.

In the meanwhile, the company needs to deliver on other items - more clarity on PDD data (peer review - taking longer than usual ?), FDA meetings for Rett, PDD, PD; Rett trials completion etc.

Enough on the plate for the next 6 to 9 months.